Platinum accumulation in oxaliplatin-induced peripheral neuropathy.

Guoli Wei, Zhancheng Gu, Jialin Gu, Jialin Yu, Xiaofei Huang, Fengxia Qin, Lingchang Li, Rong Ding, Jiege Huo

Journal: Journal of the peripheral nervous system : JPNS 2021;26(1):35-42

PMID: 33462873

Abstract

Oxaliplatin-induced peripheral neuropathy (OIPN) is a common and dose-limiting toxic effect that markedly limits the use of oxaliplatin and affects the quality of life. Although it is common, the underlying mechanisms of OIPN remain ambiguous. Recent studies have shown that the platinum accumulation in peripheral nervous system, especially in dorsal root ganglion, is a significant mechanism of OIPN. Several specific transporters, including organic cation transporters, high-affinity copper uptake protein1 (CTR1), ATPase copper transporting alpha (ATP7A) and multidrug and toxin extrusion protein 1 (MATE1), could be associated with this mechanism. This review summarizes the current research progress about the relationship between platinum accumulation and OIPN, as well as suggests trend for the future research.

© 2021 The Authors. Journal of the Peripheral Nervous System published by Wiley Periodicals LLC on behalf of Peripheral Nerve Society.

Address: Department of Oncology, Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, China.; Graduate school, Nanjing University of Chinese Medicine, Nanjing, China.; Department of Oncology, Jiangsu Province Academy of Traditional Chinese Medicine, Nanjing, China.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.